跳至主要内容
临床试验/NL-OMON51398
NL-OMON51398尚未招募不适用

Combined use of induced pluripotent stem cell derived cardiomyocytes and 3D-heart tissue to develop Therapies for pediatric heart failure in Tetratology of Fallot. - CarkiT-Fallot

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational invasive

入排标准

年龄范围
0 至 17(—)

入选标准

  • - Diagnosis as stated above
  • - Age between 0-18 years
  • - Known genetic mutation
  • - Written informed consent.

排除标准

  • - Non-consent to collect blood or residual tissue obtained at surgery or
  • transplantation.
  • - Presence of multiple mutations or deletion of chromosome.

研究者

相似试验